Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints

Mikucki, M. E., Fisher, D. T., Matsuzaki, J., Skitzki, J. J., Gaulin, N. B., Muhitch, J. B., Ku, A. W., Frelinger, J. G. +4 more·2015·Nature Communications
DOI 10.1038/ncomms8458

Cited by (512)

Items 501–512 of 512

  1. Chronic XBP1s-mediated activation of the unfolded protein response impairs CD8+ T cell anti-tumor immunity
    Keith Alan Nair, Jessica Lee, Olivia Zaleski, Luciano Mazzoccoli, Brian Deng, Chih‐Chi Andrew Hu, Stanley Ching‐Cheng Huang, Andreas Wieland, Hazem E. Ghoneim, Haitao Wen et al. · 2026 · Frontiers in Immunology
  2. Pineal melatonin modulates responsiveness to exogenous melatonin via the IFN-γ–CXCL9/10–CXCR3 axis in gastric cancer
    Wang Xiurong, Lin ChenYi, Zhang Yuyang, Linxuan Wei, Yu Zhu, Wang Rixiong, Ruixiang Zhou, Liu Hui · 2026 · Journal of Endocrinology
  3. Immune checkpoint inhibitor-associated myocarditis: clinical and mechanistic insights
    Heng Liu, Weili Li, 吴云霞, Nannan Tan, Jingmei Zhang, Yawen Zhang, Guanjing Ling, Yilin Li, Zhishu Tang, Wei Wang et al. · 2026 · Inflammation Research
  4. CXCL9-Dependent Immune Networks of Spontaneous Tertiary Lymphoid Structures in a Murine Subcutaneous Tumor Model
    Raymond Z. Qin, Hanna Abberger, Guigui Man, Benjamin J. Broomfield, Bailey E. Williams, Chin Wee Tan, Brigette C. Duckworth, Misty Rayna Jenkins, Niall D. Geoghegan, Kelly L. Rogers et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  5. CXC chemokines as context-dependent regulators of immunity, homeostasis and cancer
    Clàudia Martinez Miralles, Evangelos Manousakis, Cristina Moreta-Moraleda, Roni H G Wright · 2026 · Cellular Signalling
  6. A lactate–mitochondrial axis framework for mild hyperthermia and checkpoint blockade in driver-negative NSCLC: testing temporal coupling
    Meihan Liu, Yaoshu Song, Hongpan Zhang, Yan Gui, Daiyuan Ma · 2026 · Frontiers in Immunology
  7. Fenofibrate enhances systemic antitumor efficacy of high- and low-dose radiotherapy plus PD-1 blockade through CD8+ T-cell metabolic reprogramming and LDRT tumor conditioning
    Meidan Wang, Liqun Wang, Sagar, Xi Rao, Naghmeh Shirafkan, Yizhou Yang, Simone Gaedicke, Anca-Ligia Grosu, Elke Firat, Gabriele Multhoff et al. · 2026 · Cancer Letters
  8. Integrating physical exercise into breast cancer care: Implications for tumor development
    Inês Aires, Daniel Moreira‐Gonçalves, Rui Miguel Pinheiro Vitorino, Rita Ferreira, Paula Oliveira · 2026 · Critical Reviews in Oncology/Hematology
  9. Immune synapse in the tumor microenvironment: functional dynamics and clinical translational perspectives
    Yujie Ge, Senxu Lu, Bingqian He, Vivek P. Chavda, Jianli Gao · 2026 · Frontiers in Immunology
  10. Cold atmospheric plasma and adaptive antitumor immunity: current evidence with emphasis on T-cell responses
    Fawad Khan, Michael Peter Schön · 2026 · Frontiers in Immunology
  11. Human Intravital Microscopy
    Emmanuel M Gabriel, Diogo Moniz Garcia, Anthony Quagliano, Loizos Michaelides, Alfredo Quiñones-Hinojosa · 2026 · Methods in molecular biology
  12. Harnessing chemokines and nanocarriers to reprogram the tumor microenvironment
    Ruixue Bai, Anya Wang, Yao Li, Yunong Li, Xueyi Song, Weimin Ni, Qian Wei, Jia Bi, Minjie Wei, Lin Zhao et al. · 2026 · Drug Delivery